“We’ve been issued a Type 483 with 3 (three) observations. We’ll tackle them comprehensively throughout the stipulated timeline. At the moment, we shouldn’t have any gross sales from this plant,” it added.
As per the USFDA, Type 483 is issued to agency administration on the conclusion of an inspection when investigators have noticed any circumstances that of their judgment could represent violations of the Meals Drug and Beauty Act and associated acts.
Shares of the corporate on Wednesday ended 1.15 per cent up at Rs 4,498.65 apiece on the BSE.